Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Zacks Analyst Blog Highlights: Marathon Oil Corporation, Exxon, ConocoPhillips, Chevron and Enterprise Products Partners L.P. – Press Releases

Zacks Market Commentaries (November 4th, 2009) Writes:

For Immediate Release

Chicago, IL – November 4, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Marathon Oil Corporation (MRO), Exxon (XOM), ConocoPhillips (COP), Chevron (CVX) and Enterprise Products Partners L.P. (EPD).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Tuesday’s AnalystBlog:

Marathon Beats, Production Up

Marathon Oil Corporation’s (MRO) third-quarter 2009 results came in better-than-expected, helped by the contribution from increased oil and natural gas production. Earnings per share, excluding mark-to-market and divestment losses, came in at 61 cents, above the Zacks Consensus Estimate of 56 cents.

However, as

...

Marathon Beats, Production Up – Analyst Blog

Zacks Market Commentaries (November 3rd, 2009) Writes:
Marathon Oil Corporation’s (MRO) third-quarter 2009 results came in better-than-expected, helped by the contribution from increased oil and natural gas production. Earnings per share, excluding mark-to-market and divestment losses, came in at 61 cents, above the Zacks Consensus Estimate of 56 cents. However, as has been the case with the other oil majors that have already reported -- Exxon (XOM), ConocoPhillips (COP) and Chevron (CVX) -- earnings and revenue comparisons with the year-earlier period were quite ugly, severely hampered by lower realized commodity prices and weak refining margins. Marathon’s adjusted earnings per share plunged 77.9%, while sales declined 37.9% to $14.5 billion. Lower Prices More Than Offset Increased Upstream Volumes Income from the upstream segment totaled $491 million during the quarter, down 43.5% from the year-ago level. The company reported production (available for sale) of 393,000 oil-equivalent barrels per day (BOE/d), ...

Marathon Sells Offshore Fields – Analyst Blog

Zacks Market Commentaries (October 6th, 2009) Writes:
Marathon Oil Corporation (MRO) on Friday announced the sale of its wholly owned subsidiary, Marathon Oil Gabon Ltd. (having a 56.25% interest in three offshore production fields) to London-based independent Perenco.  The oilfields are Tchatamba Marin, Tchatamba South and Tchatamba West fields, with a combined gross production of approximately 15,000 barrels of oil per day.  Marathon has been strategically divesting assets during the last few months. These include the sale of a 20% participating interest in Angola Block 32, all of Marathon’s holdings in Ireland , interests in Heimdal area offshore Norway and interests in the Permian Basin in Texas and New Mexico.  These sales are part of the company's $2 billion to $4 billion asset divestiture program announced in March 2008. Marathon’s upstream activities are located in 11 countries, including the U.S., Canada , U.K. , Norway , Equatorial Guinea , Angola , and ...

DrStockPick.com Stock Report! 8/26/09, SGP, MRO, SCHL, BONU, INCB, PSPM

Dr. Stock Pick (August 26th, 2009) Writes:

DrStockPick.com Stock Report!

Wednesday August 26, 2009

signup3m

**************************************************************

Schering-Plough Corporation, (NYSE: SGP), today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company’s Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate for the maintenance treatment of asthma in patients 12 years of age and older. The company also announced today that the EMEA has validated the MAA for nomegestrol acetate (2.5 mg) / 17 beta-estradiol (1.5mg), a combined oral contraceptive (COC) containing a unique combination of a natural estrogen identical to the estrogen produced by a woman’s own body and a selective progestin

Marathon Oil Corporation (NYSE: MRO) announced today

...

Zacks Analyst Blog Highlights: Marathon Oil Corporation, Exxon, ConocoPhillips, Chevron and WellPoint Inc. – Press Releases

Zacks Market Commentaries (August 5th, 2009) Writes:

For Immediate Release

Chicago, IL – August 5, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Marathon Oil Corporation (MRO), Exxon (XOM), ConocoPhillips (COP), Chevron (CVX) and WellPoint Inc. (WLP).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Tuesday’s Analyst Blog:

Marathon Misses on Lower Prices

Marathon Oil Corporation (MRO) second-quarter 2009 results came in sharply weaker-than-expected, with the contribution from increased oil and natural gas production and improved refining margins more than offset by lower realized commodity prices. Earnings per share, excluding mark-to-market and divestment gains, came in

...

Marathon Misses on Lower Prices – Analyst Blog

Zacks Market Commentaries (August 4th, 2009) Writes:
Marathon Oil Corporation’s (MRO) second-quarter 2009 results came in sharply weaker-than-expected, with the contribution from increased oil and natural gas production and improved refining margins more than offset by lower realized commodity prices. Earnings per share, excluding mark-to-market and divestment gains, came in at 35 cents, below the Zacks Consensus Estimate of 53 cents.   As has been the case with the other oil majors that have already reported -- Exxon (XOM), ConocoPhillips (COP) and Chevron (CVX) -- earnings and revenue comparisons with the year-earlier period were even worse. Marathon’s adjusted earnings per share plunged 71%, while sales declined 40% to $13 billion. Lower Prices More Than Offset Increased Upstream Volumes Income from the upstream segment totaled $220 million during the quarter, down more than 73% from the year-ago level.   The company reported production (available for sale) of 411,000 oil-equivalent barrels per ...

DrStockPick.com Stock Report! NU, HOT, RTN, MRO, SMTB, CHEV

Dr. Stock Pick (July 29th, 2009) Writes:

DrStockPick.com Stock Report!

Wednesday July 29, 2009

signup3m

**************************************************************

Northeast Utilities (NYSE: NU) will webcast a conference call with financial analysts on Wednesday, August 5, 2009, beginning at 11 a.m. Eastern Daylight Time, in which senior management will discuss the company’s financial performance through the second quarter of 2009.

Rise Display, a provider of integrated solutions for both Video and LED digital signage, announces that Aloft(SM) Hotels, Starwood Hotels & Resorts Worldwide, Inc.’s (NYSE: HOT) new lifestyle brand, has incorporated LED tickers from Rise Display into the design standard for the re: mix lounge area of each of its hotels. Aloft Hotels are designed for the next generation of traveler, and

...

WMT, MCK, MRO Stock-PR NYSE Stock Report

stock-pr (July 24th, 2009) Writes:

Stock-RR Stock Report

Wal-Mart Stores Inc. (WMT) A move by Wal-Mart Stores Inc. to offer more and lower-priced laptops could give it an edge over key rival Best Buy Co. in the struggle for back-to-school electronics business.

McKesson Corp. (MCK) The Board of Directors of McKesson Corporation (NYSE:MCK - News) at its meeting today declared a regular dividend of twelve cents per share on the Common Stock, payable on October 1, 2009, to stockholders of record on September 1, 2009.

Marathon Oil Corporation (MRO) Marathon Oil Corp. agreed to sell a 20% stake in an Angolan oil-field operation for $1.3 billion to Chinese oil companies Cnooc International Ltd. and Sinopec Corp. The U.S. oil company will retain a 10% interest in the enterprise.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire

...

Zacks Bull and Bear of the Day Highlights: ExxonMobil, SurModics, Marathon Oil Corporation, CNOOC Ltd. and Sinopec – Press Releases

Zacks Market Commentaries (July 21st, 2009) Writes:

For Immediate Release

Chicago, IL – July 21, 2009 – Zacks Equity Research highlights ExxonMobil (XOM) as the Bull of the Day and SurModics (SRDX ) the Bear of the Day. In addition, Zacks Equity Research provides analysis on Marathon Oil Corporation (MRO), CNOOC Ltd. (CEO) and Sinopec (SNP).

Full analysis of all these stocks is available at http://at.zacks.com/?id=2676

Here is a synopsis of all five stocks:

Bull of the Day:

We are maintaining our Buy recommendation for ExxonMobil (XOM) shares ahead of the quarterly results, reflecting its strong operational and financial position on the back of solid business portfolio and prudent investment approach.

The company's capital spending plans remain unaffected by the current commodity-price and credit market turmoil, with annual capital outlays in the $25 billion to $30 billion range over the next five

...

Zacks Analyst Blog Highlights: Sanofi-Aventis, Biogen-Idec, Marathon Oil Corporation, Shell and StatoilHydro – Press Releases

Zacks Market Commentaries (June 26th, 2009) Writes:
For Immediate Release

Chicago, IL - June 26, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Sanofi-Aventis (SNY), Biogen-Idec (BIIB), Marathon Oil Corporation (MRO), Shell (RDS.A) and StatoilHydro (STO).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Thursday's Analyst Blog:

Sanofi Doing Deals

Sanofi-Aventis (SNY) posted EPS of e5.36 in 2008, an increase of just 2% from 2007. Revenue fell 1% in 2008 as a number of products experienced significantly declining sales including Ambien, Tritace and Copaxone.

For 2009 we expect revenue growth to return, as

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.